Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001826466-22-000111
Filing Date
2022-08-22
Accepted
2022-08-22 13:55:45
Documents
38
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 282502
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7248
3 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3222
  Complete submission text file 0001826466-22-000111.txt   1609981

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nika-20220630.xsd EX-101.SCH 14482
5 XBRL CALCULATION FILE nika-20220630_cal.xml EX-101.CAL 19905
6 XBRL DEFINITION FILE nika-20220630_def.xml EX-101.DEF 44052
7 XBRL LABEL FILE nika-20220630_lab.xml EX-101.LAB 133831
8 XBRL PRESENTATION FILE nika-20220630_pre.xml EX-101.PRE 107809
32 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 117134
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56234 | Film No.: 221183152
SIC: 3790 Miscellaneous Transportation Equipment